Davis's Drug Guide
lumacaftor/ivacaftor
General
Genetic Implications:
Pronunciation:
loo-ma-kaf-tor/eye-va-kaf-tor
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Orkambi
Ther. Class.
cystic fibrosis therapy adjuncts
Pharm. Class.
transmembrane conductance regulator potentiators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Lumacaftor/ivacaftor." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/110659/all/lumacaftor_ivacaftor.
Vallerand AHA, Sanoski CAC, Quiring CC. Lumacaftor/ivacaftor. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110659/all/lumacaftor_ivacaftor. Accessed June 3, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Lumacaftor/ivacaftor. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110659/all/lumacaftor_ivacaftor
Vallerand AHA, Sanoski CAC, Quiring CC. Lumacaftor/ivacaftor [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 June 03]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110659/all/lumacaftor_ivacaftor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - lumacaftor/ivacaftor
ID - 110659
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110659/all/lumacaftor_ivacaftor
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -